Patent directory · USPTO A61K / A61P
Patents matching “Provectus Pharmatech, Inc.”
25 pharma patents match "Provectus Pharmatech, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 25 pharmaceutical patents matching "Provectus Pharmatech, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12377068
In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumors
granted -
US 12133840
Halogenated xanthene composition and method for treating hematologic cancers
granted -
US 12064507
Composition and method for oral treatment of leukemia
granted -
US 11975106
Uses of halogenated xanthenes in oncology and virology
granted -
US 11974980
In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumors
granted -
US 11938182
Halogenated xanthenes as vaccine adjuvants
granted -
US 11426379
Combination of local and systemic therapies for enhanced treatment of dermatologic conditions
granted -
US 11419844
Halogenated xanthene composition and method for treating hematologic cancers
granted -
US 11071781
Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer
granted -
US 11058664
In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumors
granted -
US 10471144
Combination of local rose bengal and systemic immunomodulative therapies for enhanced treatment of cancer
granted -
US 10130658
Method of ex vivo enhancement of immune cell activity for cancer immunotherapy with a small molecule ablative compound
granted -
US 9839688
Combination of rose bengal and systemic immunomodulative therapies for enhanced treatment of cancer
granted -
US 9808524
Combination of local and systemic immunomodulative therapies for melanoma and liver cancer
granted -
US 9422260
Process for the synthesis of 4,5,6,7-tetrachloro-3′,6′-dihydroxy-2′,4′,5′,7′-tetraiodo-3H-spiro[isobenzofuran-1,9′-xanthen]-3-one(Rose Bengal) and related xanthenes
granted -
US 8974363
Topical medicaments and methods for photodynamic treatment of disease
granted -
US 8557298
Medicaments for chemotherapeutic treatment of disease
granted -
US 8470296
Intracorporeal medicaments for high energy phototherapeutic treatment of disease
granted -
US 7863047
Intracorporeal medicaments for photodynamic treatment of disease
granted -
US 7648695
Medicaments for chemotherapeutic treatment of disease
granted -
US 7427389
Diagnostic agents for positron emission imaging using radiolabeled halogenated xanthenes
granted -
US 7402299
Intracorporeal medicaments for photodynamic treatment of disease
granted -
US 7390668
Intracorporeal medicaments for photodynamic treatment of disease
granted -
US 7384623
High energy phototherapeutic agents
granted